scholarly journals Oropouche virus: poised for headlines?

2017 ◽  
Vol 39 (3) ◽  
pp. 12-17
Author(s):  
Natasha Louise TilstonLunel

Oropouche virus (OROV) is a midge-borne human pathogen that causes periodic outbreaks of a flulike illness predominately in the Northern parts of Brazil. However, despite its significant public health importance in Central and South America the virus remains rather obscure to the rest of the world.

2020 ◽  
Vol 15 ◽  
pp. 4
Author(s):  
Sanju George ◽  
Jessy Fenn ◽  
Kripa Robonderdeep

Gambling is a popular pastime in India, as in most cultures across the world. Although research from India is limited, there is enough evidence to suggest that it should be of public health importance. In this brief paper, we look at the evolution of gambling in India and also discuss potential ways forward to address this issue.


2021 ◽  
Vol 49 (1) ◽  
Author(s):  
Mainak Bardhan ◽  
Debolina Pramanik ◽  
Rizana Riyaz ◽  
Mohammad Mehedi Hasan ◽  
Mohammad Yasir Essar

AbstractThe COVID-19 pandemic has wreaked havoc in the world from last year, and any further insults like Zika virus will surely bring the apocalypse unto us. In July 2021, Zika began spreading in India, mainly in the state of Kerala. Zika infection resembles closely COVID-19 and other arboviral infections, which might lead to delayed and misdiagnosis, further leading to underreporting of cases. Some of the feared complications of Zika include Guillain–Barré syndrome and congenital Zika syndrome leading to microcephaly. Thus, Zika virus disease (ZVD) has significant public health and social impacts. Since the trifecta of infectious diseases (host, agent and environment) are all conducive to the spread of Zika in India, there is a huge risk that ZVD might become endemic in India, which is especially dangerous in the backdrop of this pandemic. This has to be stopped at all costs: the main aspects of which are public health measures, vector control and early diagnosis, especially in case of pregnant women. The diversion of healthcare resources for this pandemic has albeit made this difficult, but we must do our bit if we have to overcome this situation.


2004 ◽  
Vol 70 (12) ◽  
pp. 7574-7577 ◽  
Author(s):  
Ling Zhou ◽  
Ronald Fayer ◽  
James M. Trout ◽  
Una M. Ryan ◽  
Frank W. Schaefer ◽  
...  

ABSTRACT Of 471 specimens examined from foxes, raccoons, muskrats, otters, and beavers living in wetlands adjacent to the Chesapeake Bay, 36 were positive for five types of Cryptosporidium, including the C. canis dog and fox genotypes, Cryptosporidium muskrat genotypes I and II, and Cryptosporidium skunk genotype. Thus, fur-bearing mammals in watersheds excreted host-adapted Cryptosporidium oocysts that are not known to be of significant public health importance.


2020 ◽  
pp. 1-10
Author(s):  
Addis Adera Gebru ◽  
Tadesse Birhanu ◽  
Eshetu Wendimu ◽  
Agumas Fentahun Ayalew ◽  
Selamawit Mulat ◽  
...  

BACKGROUND: The novel Coronavirus Diseases 2019 (COVID-19) is the major public health burden in the world. The morbidity and mortality of global community due to this disease is dramatically increasing from time to time. OBJECTIVE: This situational analysis is aimed to analysis prevalence, and incidence of COVID-19 and to provide clear information about this disease for the scientific community, stakeholders and healthcare practitioners and decision-makers. METHODS: The literatures were identified by searching the key relevant and officially known online databases: medRxiv, Google scholar and PubMed. The online databases contain archives of most English biomedical journals and scientific papers published online from 31 December to 3 April 2020 were included. After the literature search, articles were screened independently by two reviewers for eligibility. RESULTS: The world continents have confirmed a total of 1,202,320 confirmed COVID-19 cases: (51.2%) in Europe, (27.7%) in North America, (17.9%) in Asia, (1.96%) in South America and at less number of confirmed COVID-19 cases in Africa and Australia which was accounted 0.8% and 0.5%, respectively. However, this review showed that there was significantly increased the confirmed COVID-19 cases by 109,555 in Asia, 8,658 in Africa, 332,866 in North America, 20,269 in South America, 568,894 in Europe, 5,051 in Australia and 1,045,403 in the whole world continent except Antarctica during the review period. The overall results showed that there were 1,098,762 cases and 59,172 deaths have recorded from during the review period. The result zero number of deaths with COVID-19 was observed in 66 countries. CONCLUSION: The review concluded that COVID-19; SARS-CoV-2 is the major public health burden in the world, the morbidity and mortality of global community is dramatically increasing from time to time. Strongly collaboration among all sectors and then design effective prevention and control strategies which include staying home, social/physical distancing, quarantine, testing of suspected patients, isolation and managing of the confirmed cases. Therefore, the world continents countries should have to implement five major COVID-19 prevention and control programmes as soon as possible at community level.


2015 ◽  
Vol 11 (1) ◽  
pp. 115
Author(s):  
Stephen H LaFranchi, MD ◽  

Despite the fact that programs began detecting neonates with congenital hypothyroidism (CH) over 40 years ago, at present only 30 % of the world birth population (approximately 127 million) undergoes screening for this disorder. The estimated cost of detection by screening, $15,400 compares with a lifetime expense of $1,296,000 in developed countries. The annual cost of the 30,000 CH cases not identified and treated early is approximately $40 billion dollars. Increasing the coverage of newborn screening worldwide remains a significant public health challenge.


Pathogens ◽  
2019 ◽  
Vol 8 (4) ◽  
pp. 188
Author(s):  
Austin ◽  
Galasso ◽  
Nickens ◽  
Knollmann-Ritschel ◽  
Sharma

Zika virus’s (ZIKV) emergence as a pathogen of significant public health importance has accelerated efforts to develop a ZIKV vaccine. To date, the need for an effective ZIKV vaccine is unmet. In this study, we report inactivation of ZIKV using a hydrophobic photoactive compound: 1, 5 iodonaphthyl azide (INA). 50 and 100 µM of INA completely inactivated ZIKV (INA-ZIKV). Western blot and ELISA analysis show some loss of the binding capacity of INA-iZIKV to anti-ZIKV monoclonal antibodies; however, immunization of mice with INA-iZIKV demonstrated seroconversion and ZIKV-neutralizing antibody response. RNA isolated from INA-iZIKV did not induce productive infection in Vero cells, suggesting inactivation of ZIKV RNA. These results suggest that in the absence of an approved ZIKV vaccine, INA-iZIKV can be pursued as a viable ZIKV vaccine candidate.


2020 ◽  
Vol 13 (11) ◽  
pp. 503
Author(s):  
AhmadAli Hanafi-Bojd ◽  
Javad Rafinejad ◽  
Mehran Shahi ◽  
Shahrokh Navidpour ◽  
Elham Jahanifard

2011 ◽  
Vol 26 (S2) ◽  
pp. 2137-2137
Author(s):  
N. Sartorius

Aware of the huge and growing public health importance of depressive disorders the World Psychiatric Association developed an educational programme that brought together materials that psychiatrists could use in teaching other medical staff - for example general practitioners - about depression and its management. The programme was translated in many languages and widely used. Reports about the usefulness of the programme were very positive and usually drew attention to the fact that the programme contained a large amount of data that could be used in composing teaching curricula appropriate for the different settings in which the training was to take place. The experience gained in the use of the programme guided the development of the updated version of the programme released in 2009. As in the first edition, information was made available so that teachers could use in composing their educational activities. In addition however, a special chapter has been added to the programme addressing the role of culture in the presentation of depression and in its management. The presentation will describe the programme and its development. It will in particular describe the parts of the programme dealing with cultural issues and with the methods of education of general practitioners.


2019 ◽  
Vol 4 (Suppl 3) ◽  
pp. A5.3-A6
Author(s):  
Agnes Saint-Raymond ◽  
Martin Harvey ◽  
Maria Cavaller

BackgroundThe European legislation introduced in 2004 (under article 58) a collaboration tool to increase access to high quality and effective medicines in low- and middle-income countries. The European Medicines Agency (EMA) can provide scientific opinions on medicines intended for significant public health needs, in partnership with the World Health Organisation (WHO) and the relevant ‘target’ non-EU regulatory authorities. This EU-Medicines4all (EU-M4all) initiative contributes to the broader Global Health Mandate of the EU.MethodsWe contacted the pharmaceutical companies holding ‘article 58’ scientific opinions and compiled the number of actual approvals based on these opinions.ResultsNine medicines have been assessed so far, most of them for HIV/AIDS, tuberculosis, malaria and maternal/new-born health. Although this figure may appear low, the impact of the corresponding scientific opinions is much wider. Approvals were granted in 66 different countries worldwide, 38 of which are in Africa, based on these opinions.DiscussionSuch scientific opinions on the quality, safety and efficacy of the medicines are provided by the EMA’s Committee for Medicinal Products for Human Use (CHMP). Prior to this, it is recommended to agree on the data to be generated through scientific advice. The opinions are based on the same standards as used for those approved for Europe, with considerations for local conditions of use. To promote reliance on EMA scientific outputs and awareness of the procedure, two training events with regulators from Southern and from Western Africa are organised in partnership with WHO, NEPAD and local regulators in June 2018.ConclusionWe have shown that this ‘article 58’ procedure has a true impact and we encourage applications by companies developing medicines, aimed to prevent or treat diseases of significant public health interest, to be marketed outside the EU. This will ensure timely access of medicines by patients in target countries all over the world.


2021 ◽  
pp. 004947552110108
Author(s):  
P Karpaga Priya ◽  
Pragyan P Parija ◽  
Anubhuti Kujur

Tetanus is one of the dreaded fatal diseases which is of public health importance. Reducing the morbidity and mortality due to tetanus, especially maternal and neonatal, is one of the major aims of health organizations around the world. Vaccination against tetanus is one of the most salient interventions. In order to ensure the unerring vaccination practices, the World Health Organization has been updating its position papers on all vaccines. To enable India to follow the appropriate vaccine policy, this article highlights the category and situation-based schedule of tetanus toxoid vaccination.


Sign in / Sign up

Export Citation Format

Share Document